Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for prostate cancer, hereditary, 14 has been reported in the published literature.
No clinical trials have been registered for prostate cancer, hereditary, 14.
7 publications have been identified in PubMed for prostate cancer, hereditary, 14. Research spans Diagnostic / Biomarker (29%), Review / Meta-Analysis (14%), and Case Report / Case Series (14%).
Tsumura H (2025). [PMID: 41158701](https://pubmed.ncbi.nlm.nih.gov/41158701/). *Mol Clin Oncol*. [Review / Meta-Analysis]
Carrerette FB (2025). [PMID: 41267989](https://pubmed.ncbi.nlm.nih.gov/41267989/). *Front Oncol*. [Case Report / Case Series]
Jurecka-Lubieniecka B (2025). [PMID: 41294693](https://pubmed.ncbi.nlm.nih.gov/41294693/). *Curr Oncol*. [Diagnostic / Biomarker]
Muniroh M (2025). [PMID: 41407742](https://pubmed.ncbi.nlm.nih.gov/41407742/). *Sci Rep*. [Basic Science / Preclinical]
Byrne L (2025). [PMID: 40533153](https://pubmed.ncbi.nlm.nih.gov/40533153/). *J Med Genet*. [Diagnostic / Biomarker]
Kwon DH (2024). [PMID: 39254645](https://pubmed.ncbi.nlm.nih.gov/39254645/). *JNCI Cancer Spectr*. [Epidemiology / Natural History]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 4:49 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Choudry MM (2024). [PMID: 38860938](https://pubmed.ncbi.nlm.nih.gov/38860938/). *J Urol*. [Clinical Trial Publication]